Solux pledges 14.67% stake in Aribio Lab for 4 billion KRW new loan, repays existing debt
Solux the largest shareholder of Aribio Lab entered into a new stock-backed loan agreement with Sangsangin Securities collateralizing its entire stake of 3,948,813 shares representing 14.67% of the outstanding shares for 4 billion KRW.
The new loan replaces an existing stock-backed loan and carries a three-month term with an 8% interest rate and a 175% maintenance ratio.
Since the transaction is a refinancing of existing debt there is no change in share count or dilution but the high pledge ratio increases the risk of forced liquidation if the stock price falls significantly.
[AI Summary]Solux's refinancing of its stock-backed loan has limited near-term impact but the large collateral position creates downside risk for shareholders should the share price decline.